Home
Lynwood Capital Management reported a 5% stake in Rein Therapeutics RNTX · 4,280,500 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 5%
- Last report
- 6.1% · filed 26/05/08
- Shares held
- 4,280,500 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 26/06/30
- Filed
- 26/08/14
5% stake · −1.1pp from the last report
- Stake
- 5%
- Last report
- 6.1%
- Since last report
- −1.1pp
Rein Therapeutics trades, last 26 weeks
What else happened in Rein Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Lynwood Capital Management's other 5% stake reports
- Lynwood Capital Management
5% stakeKazia Therapeutics
5% stakeKazia Therapeutics
KZIA
4.6% stake
264,980,500 sh
4.6% stake
Filed 08/14
- Lynwood Capital Management
5% stakeRein Therapeutics
5% stakeRein Therapeutics
RNTX
6.1% stake
4,750,000 sh
6.1% stake
Filed 05/08
- Lynwood Capital Management
5% stakeKazia Therapeutics
5% stakeKazia Therapeutics
KZIA
5.4% stake
307,998,500 sh
5.4% stake
Filed 01/23
